Revvity (RVTY) Revenue & Revenue Breakdown
Revvity Revenue Highlights
Latest Revenue (Y)
$2.76B
Latest Revenue (Q)
$698.95M
Main Segment (Y)
Diagnostics
Main Geography (Y)
Other International
Revvity Revenue by Period
Revvity Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-29 | $2.76B | 0.16% |
| 2023-12-31 | $2.75B | -16.95% |
| 2022-12-31 | $3.31B | -34.64% |
| 2021-12-31 | $5.07B | 33.95% |
| 2020-12-31 | $3.78B | 31.18% |
| 2019-12-31 | $2.88B | 3.80% |
| 2018-12-31 | $2.78B | 23.08% |
| 2017-12-31 | $2.26B | 6.69% |
| 2016-12-31 | $2.12B | -6.49% |
| 2015-12-31 | $2.26B | 1.12% |
| 2014-12-31 | $2.24B | 3.28% |
| 2013-12-31 | $2.17B | 2.41% |
| 2012-12-31 | $2.12B | 10.09% |
| 2011-12-31 | $1.92B | 12.73% |
| 2010-12-31 | $1.70B | -5.95% |
| 2009-12-31 | $1.81B | -6.47% |
| 2008-12-31 | $1.94B | 8.40% |
| 2007-12-31 | $1.79B | 15.58% |
| 2006-12-31 | $1.55B | 4.92% |
| 2005-12-31 | $1.47B | -12.65% |
| 2004-12-31 | $1.69B | 9.90% |
| 2003-12-31 | $1.54B | 2.01% |
| 2002-12-31 | $1.50B | 13.15% |
| 2001-12-31 | $1.33B | -21.54% |
| 2000-12-31 | $1.70B | 24.37% |
| 1999-12-31 | $1.36B | -3.18% |
| 1998-12-31 | $1.41B | -3.62% |
| 1997-12-31 | $1.46B | 2.35% |
| 1996-12-31 | $1.43B | 0.54% |
| 1995-12-31 | $1.42B | 6.53% |
| 1994-12-31 | $1.33B | -50.61% |
| 1993-12-31 | $2.70B | - |
Revvity generated $2.76B in revenue during NA 2024, up 0.16% compared to the previous quarter, and up 95.54% compared to the same period a year ago.
Revvity Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-28 | $698.95M | -2.96% |
| 2025-06-29 | $720.28M | 8.35% |
| 2025-03-30 | $664.76M | -8.86% |
| 2024-12-29 | $729.37M | 6.63% |
| 2024-09-29 | $684.05M | -1.10% |
| 2024-06-30 | $691.68M | 6.43% |
| 2024-03-31 | $649.92M | -6.61% |
| 2023-12-31 | $695.90M | 3.75% |
| 2023-09-30 | $670.74M | -5.41% |
| 2023-06-30 | $709.07M | 5.07% |
| 2023-04-02 | $674.87M | -8.95% |
| 2022-12-31 | $741.21M | 4.13% |
| 2022-10-02 | $711.80M | -20.53% |
| 2022-06-30 | $895.64M | -7.01% |
| 2022-03-31 | $963.16M | -6.30% |
| 2021-12-31 | $1.03B | 19.34% |
| 2021-09-30 | $861.32M | -29.89% |
| 2021-06-30 | $1.23B | -6.06% |
| 2021-03-31 | $1.31B | -3.46% |
| 2020-12-31 | $1.35B | 40.52% |
| 2020-09-30 | $964.02M | 18.76% |
| 2020-06-30 | $811.72M | 24.42% |
| 2020-03-31 | $652.40M | -19.01% |
| 2019-12-31 | $805.50M | 13.94% |
| 2019-09-30 | $706.92M | -2.16% |
| 2019-06-30 | $722.52M | 11.37% |
| 2019-03-31 | $648.74M | -14.23% |
| 2018-12-31 | $756.35M | 12.17% |
| 2018-09-30 | $674.31M | -4.13% |
| 2018-06-30 | $703.36M | 9.22% |
| 2018-03-31 | $643.97M | 0.37% |
| 2017-12-31 | $641.63M | 15.76% |
| 2017-09-30 | $554.27M | 1.34% |
| 2017-06-30 | $546.96M | 6.39% |
| 2017-03-31 | $514.12M | -9.29% |
| 2016-12-31 | $566.77M | 3.41% |
| 2016-09-30 | $548.05M | -4.30% |
| 2016-06-30 | $572.67M | 6.31% |
| 2016-03-31 | $538.68M | -11.42% |
| 2015-12-31 | $608.12M | 7.93% |
| 2015-09-30 | $563.44M | -0.08% |
| 2015-06-30 | $563.91M | 7.02% |
| 2015-03-31 | $526.90M | -13.39% |
| 2014-12-31 | $608.39M | 12.24% |
| 2014-09-30 | $542.05M | -2.54% |
| 2014-06-30 | $556.17M | 4.56% |
| 2014-03-31 | $531.90M | -10.35% |
| 2013-12-31 | $593.28M | 13.16% |
| 2013-09-30 | $524.28M | -3.50% |
| 2013-06-30 | $543.30M | 7.50% |
| 2013-03-31 | $505.38M | -11.79% |
| 2012-12-31 | $572.92M | 12.42% |
| 2012-09-30 | $509.60M | -2.34% |
| 2012-06-30 | $521.79M | 2.13% |
| 2012-03-31 | $510.89M | -5.42% |
| 2011-12-31 | $540.19M | 19.05% |
| 2011-09-30 | $453.74M | -5.37% |
| 2011-06-30 | $479.49M | 7.06% |
| 2011-03-31 | $447.86M | -4.70% |
| 2010-12-31 | $469.97M | 12.13% |
| 2010-09-30 | $419.14M | -15.81% |
| 2010-06-30 | $497.84M | 7.04% |
| 2010-03-31 | $465.09M | -8.62% |
| 2009-12-31 | $508.99M | 16.46% |
| 2009-09-30 | $437.06M | 0.57% |
| 2009-06-30 | $434.57M | 0.70% |
| 2009-03-31 | $431.57M | 2.42% |
| 2008-12-31 | $421.37M | -16.58% |
| 2008-09-30 | $505.12M | -4.45% |
| 2008-06-30 | $528.64M | - |
Revvity generated $698.95M in revenue during Q3 2025, up -2.96% compared to the previous quarter, and up 101.05% compared to the same period a year ago.
Revvity Revenue Breakdown
Revvity Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Life Sciences | $1.25B |
| Diagnostics | $1.50B |
Revvity's latest annual revenue breakdown by segment (product or service), as of Dec 24: Diagnostics (54.48%), and Life Sciences (45.52%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 |
|---|---|---|---|---|---|---|
| Life Sciences | $342.82M | $365.90M | $340.39M | $953.22M | $300.92M | - |
| Diagnostics | $356.13M | $354.39M | $324.37M | $1.12B | $383.13M | - |
| Service | - | - | - | - | - | $84.17M |
| Product | - | - | - | - | - | $565.75M |
Revvity's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Diagnostics (50.95%), and Life Sciences (49.05%).
Revvity Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 |
|---|---|
| CHINA | $450.01M |
| UNITED STATES | $1.10B |
| UNITED KINGDOM | $112.88M |
| Other International | $2.75B |
Revvity's latest annual revenue breakdown by geography, as of Dec 24: Other International (62.36%), UNITED STATES (24.88%), CHINA (10.20%), and UNITED KINGDOM (2.56%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Sep 24 | Mar 24 |
|---|---|---|---|---|---|
| Americas | $307.28M | $323.58M | $304.63M | $302.32M | $294.35M |
| Europe | $202.40M | $203.63M | $181.79M | $182.04M | $178.56M |
| Asia | $189.28M | $193.07M | $178.34M | $199.69M | $177.00M |
Revvity's latest quarterly revenue breakdown by geography, as of Sep 25: Americas (43.96%), Europe (28.96%), and Asia (27.08%).
Revvity Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RDY | Dr. Reddy's Laboratories | $279.16B | - |
| SOLV | Solventum | $8.25B | $2.10B |
| ICLR | ICON Public | $8.12B | $2.09B |
| ENSG | Ensign Group | $4.26B | $1.30B |
| CRL | Charles River Laboratories | $4.05B | $1.00B |
| ALGN | Align | $4.00B | $995.69M |
| EXAS | Exact Sciences | $2.76B | $850.74M |
| RVTY | Revvity | $2.76B | $698.95M |
| QGEN | Qiagen | $1.97B | $458.80M |
| HIMS | Hims & Hers Health | $1.48B | $598.98M |
| GH | Guardant Health | $739.02M | $265.20M |